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Major histocompatibility class I molecules display tens of thousands of peptides on the cell surface for immune
surveillance by T cells. The peptide repertoire represents virtually all cellular translation products, and can thus reveal
a foreign presence inside the cell. These peptides are derived from not only conventional but also cryptic translational
reading frames, including some without conventional AUG codons. To define the mechanism that generates these
cryptic peptides, we used T cells as probes to analyze the peptides generated in transfected cells. We found that when
CUG acts as an alternate initiation codon, it can be decoded as leucine rather than the expected methionine residue.
The leucine start does not depend on an internal ribosome entry site–like mRNA structure, and its efficiency is
enhanced by the Kozak nucleotide context. Furthermore, ribosomes scan 59 to 39 specifically for the CUG initiation
codon in a eukaryotic translation initiation factor 2–independent manner. Because eukaryotic translation initiation
factor 2 is frequently targeted to inhibit protein synthesis, this novel translation mechanism allows stressed cells to
display antigenic peptides. This initiation mechanism could also be used at non-AUG initiation codons often found in
viral transcripts as well as in a growing list of cellular genes.
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Introduction
Immune surveillance by cytotoxic T cells (CTLs) is a key
mechanism for detecting and eliminating abnormal cells.
These include cells infected with viruses or bacteria, and
those that have suffered tumorigenic transformations (Town-
send and Bodmer 1989). The antigen receptors of CTLs probe
the repertoire of peptide/major histocompatibility complex
(MHC) class I complexes on the target cell surface. Target
cells display peptides derived from virtually all cellular
translation products; the presence of foreign peptides, such
as those derived from viral proteins, can trigger a T cell
response. Each cell presents tens of thousands of distinct
peptides as potential ligands for the CTL antigen receptor
(Rammensee et al. 1993; Engelhard 1994). Most peptides are
represented at fewer than ten copies per cell, and by some
estimates only three copies of the antigenic peptide are
sufﬁcient for target cell lysis (Purbhoo et al. 2004). CTLs are
thus a very sensitive probe for the peptides displayed by MHC
class I.
The antigen-presenting cells (APCs), which include almost
all nucleated cells, are also very efﬁcient in generating
peptides for display by MHC class I (Pamer and Cresswell
1998; Princiotta et al. 2003). In fact, they are so efﬁcient that
the complex mixture of peptides on the cell surface includes
some peptides that should in theory never have been
translated in the ﬁrst place (Shastri et al. 2002). These
peptides, referred to as ‘‘cryptic,’’ are derived from the 59 and
39 ‘‘untranslated’’ regions of the RNA or from alternate
translational reading frames. Cryptic peptides have been
identiﬁed as targets for CTLs speciﬁc for tumors as well as
virus-infected cells (Mayrand and Green 1998; Cardinaud et
al. 2004). Several studies have shown that these peptides can
arise in tumor cells and cultured cell lines despite the absence
of conventional AUG codons (Malarkannan et al. 1995a;
Dolstra et al. 1999; Malarkannan et al. 1999; Ronsin et al.
1999). Recently, using a transgenic approach we demonstra-
ted that such peptides can also be expressed in a variety of
normal cells and can elicit CTL responses (Schwab et al.
2003). Remarkably, a distinct translation mechanism ap-
peared to be responsible for their generation, because it was
capable of decoding the CUG initiation codon as leucine
rather than the expected methionine residue.
How APCs generate peptides using non-AUG codons
remains obscure. It is believed that cells express only one
class of initiator tRNA, RNAi
Met, which is speciﬁc for AUG
and is always charged with the methionine residue (Peabody
1989; Rajbhandary and Chow 1995). 40S ribosomes are
preloaded with RNAi
Met and other initiation factors even
before they approach the mRNA to be translated. Initiation
at non-AUG codons is therefore thought to be caused by
‘‘wobble’’ in the pairing of the non-AUG codon with the
anticodon of the RNAi
Met (Peabody 1989). This mispairing
results in incorporation of the methionine residue at the
non-AUG initiation codon. How cells initiate translation with
a nonmethionine residue is thus not explained by current
translational theory. It is nevertheless important to under-
stand this mechanism not only because antigenic peptides
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because expression of a growing number of genes appears
to be mediated by translation initiated at non-AUG codons.
In this study, we used T cells as probes to analyze the
translation mechanism that allows the generation of CUG-
initiated antigenic peptides and decodes CUG as the leucine
rather than the methionine residue. We found some
similarities, but also key differences, between the translation
mechanisms mediating initiation at conventional AUG versus
CUG codons.
Results/Discussion
Decoding of the CUG Initiation Codon as Leucine Does
Not Depend upon the mRNA Sequence
We had previously shown both in transfected cell lines and
in a transgenic mouse model that CUG can be decoded as
leucine when it serves as the initiation codon for the (CTG)-
TFNYRNL peptide (the initiation codon is in parentheses and
the remaining amino acids are in single-letter code)
(Malarkannan et al. 1999; Schwab et al. 2003). Although there
are numerous examples of non-AUG initiation codons, this is
to our knowledge the only known instance in which the
identity of the ﬁrst residue was investigated and found not to
be methionine, with the exception of initiation directed by
cricket paralysis virus-like internal ribosome entry sites (CPV-
IRES). Normally the RNAi
Met occupies the P site of the
ribosome, where translation initiation begins. In contrast, the
CPV-IRES binds the ribosome and positions it precisely so
that initiation begins in the A site, without requiring RNAi
Met
(Jan and Sarnow 2002). In the cricket paralysis virus,
initiation begins with alanine encoded by GCU, and in the
Plautia stali intestine virus initiation begins with glutamine
encoded by CAA (Sasaki and Nakashima 2000; Wilson et al.
2000). Because there was no obvious IRES-like sequence in
the transgene we had used, and non-CUG leucine codons
failed to direct efﬁcient translation, we suspected that a
different mechanism might account for initiation at the CUG
codon (Schwab et al. 2003). Therefore we ﬁrst asked whether
the leucine start was dependent upon the mRNA sequence.
To address this question, we identiﬁed the ﬁrst amino acid
of CUG-initiated peptides that were presented by MHC class I
molecules and thus detectable by appropriate T cells. In this
assay, we cotransfected cells with cDNA constructs encoding
the peptide as well as the MHC molecule that binds and
presents the peptide on the cell surface. Binding to the MHC
protects the initiation residue from being removed by
cellular proteases, which can trim antigenic peptides in the
cytoplasm or the endoplasmic reticulum (Kloetzel 2004; Rock
et al. 2004). We then extracted the peptides translated in the
cells and separated them by reverse-phase high performance
liquid chromatography (RP-HPLC), using conditions in which
the methionine-initiated peptide elutes at a different time
from the leucine-initiated peptide. Finally, we assayed the
HPLC fractions for the presence of the peptide. We added to
each fraction a T cell hybridoma that cross-reacts with the
methionine and the leucine-initiated forms of the peptide, as
well as appropriate APCs that will display the peptide on
their MHC molecules. We measured the T cell response to
each fraction. By comparing the retention time of the T cell-
stimulating fractions from the cell extract with the retention
time of synthetic peptides, we can determine the identity of
the peptide made by the cells. This assay has several
advantages over conventional assays used to detect initiating
amino acids: MHC molecules protect the ﬁrst amino acid
from cleavage, T cells can detect nonmethionine residues
with high sensitivity, and we can analyze the products of
translation initiation in vivo.
To determine if decoding of the CUG initiation codon as
leucine was inﬂuenced by 59 or 39 untranslated regions
(UTRs) of the mRNA, we transfected COS-7 cells with cDNA
encoding the K
b MHC molecule and the *(CTG)-TFNYRNL*
peptide ([CTG]YL8). We refer to this as the xYL8 model. We
placed the peptide in three different contexts: ﬁrst, in the
pcDNA1 vector; second, upstream of the IRES in the pIRES2-
eGFP vector; and, ﬁnally, in the 59 UTR of green ﬂuorescent
protein (GFP) in the pcDNA1 vector. The peptides translated
in the transfected cells were extracted and fractionated by
HPLC. Each fraction was tested for the presence of the
leucine-initiated LTFNYRNL (LYL8) peptide and the me-
thionine-initiated MTFNYRNL (MYL8) peptide using BCZ103
T cells and K
b-expressing L cells (a ﬁbroblast cell line) as
APCs. With each construct we found a single peak of
antigenic activity that eluted in the same fraction as the
synthetic LYL8 peptide (Figure 1A–1C). In contrast, when the
cells were transfected with a construct encoding the ATG-
initiated peptide ([ATG]-TFNYRNL), the single peak of
antigenic activity eluted in fractions identical to those
containing the synthetic MYL8 peptide (Figure 1A and 1D).
This result rules out the possibility that the apparent use of
leucine was due to post-translational modiﬁcation of the
MYL8 peptide, which caused it to coelute with the LYL8
peptide. We conclude that the cells were capable of decoding
the initiating CTG codon as leucine regardless of the 59 or 39
sequences ﬂanking the LYL8 coding sequence.
We next tested whether the LYL8 coding sequence itself
enabled the leucine start. We examined the initiating amino
acid used for a different peptide presented by the D
b MHC
class I molecule that satisﬁed the conditions required for our
assay: that an MHC molecule present the peptide, that HPLC
allow distinction between the leucine- and methionine-
initiated forms, and that a T cell cross-react with the peptides
with leucine or methionine residues at the ﬁrst position.
When COS-7 cells were transfected with cDNA constructs
encoding the D
b MHC molecule and the *(CTG)-SNEN-
METM peptide derived from the inﬂuenza nucleoprotein,
only the leucine-initiated LM9 peptide was detected in the
HPLC-fractionated cell extracts (Figure 1E and 1F). We again
assessed whether the apparent use of leucine could be due to
post-translational modiﬁcation of the methionine-initiated
peptide. We transfected cells with a construct containing the
ATG initiation codon in place of the CTG codon. Analysis of
cell extracts after HPLC fractionation now revealed a single
peak of antigenic activity that eluted in the same fractions as
the synthetic MM9 peptide (Figure 1E and 1G). Similar results
were also obtained with the (CTG)-SHL8 peptide that was
presented by the D
b MHC class I molecule (Malarkannan et al.
1995b) (unpublished data). We conclude that the peptide
sequence itself was irrelevant to the decoding of the CTG
initiation codon as leucine.
At present it is difﬁcult to quantify the fraction of the total
translated material that is initiated with leucine, because the
different peptides may have different stabilities in the cell.
Furthermore, the T cell hybridomas could respond to the
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sensitivities. Indeed, the BCZ103 T cell hybridoma responds
to LYL8 approximately 30-fold better than to MYL8 (Figure
1H). In contrast, the DBFZ T cell hybridoma recognizes its
leucine- or methionine-initiated cognate peptides with
comparable sensitivity (Figure 1I). Nonetheless, translational
initiation with the leucine residue is readily detected.
In previous studies, we explored the possibility that leucine
was used as the ﬁrst amino acid because the ribosome may
have begun at an upstream alternate initiation codon (there
are no upstream ATGs in these constructs) and read through
the stop codon before the CTG initiation codon in the LYL8
coding sequence. We showed that increasing the number of
stop codons upstream of CTG from one to six had no effect
on LYL8 expression, and that substituting the CTG codon
with other leucine-encoding triplets essentially ablated
peptide expression (Malarkannan et al. 1999; Schwab et al.
2003). We assessed the possibility of translational read-
through in the different model systems used here. If read-
through were responsible for LYL8 expression, one would
predict that expression of the downstream LYL8 would be
proportional to expression of the upstream sequence. To test
this hypothesis, we made DNA constructs in which the LYL8
coding sequence was placed directly after the stop codon
terminating translation of another peptide, SSVVGVWYL
(SVL9) (Mendoza et al. 1997). We then placed the
[SVL9*LYL8] cassette in-frame (R0) with and out-of-frame
(R1) with an ATG initiation codon (Figure 2A). These
constructs were transfected into cells along with the
appropriate MHC molecules, and peptide expression was
assayed with the 30NX/B10Z T cell hybridoma speciﬁc for the
SVL9/D
b complex (Figure 2B) and the BCZ103 T cell
hybridoma speciﬁc for the LYL8/K
b complex (Figure 2C). T
cells were added directly to the transfected cells without an
intervening extraction step. Cells expressing the R0 cassette
were highly active as APCs. Shifting the cassette out-of-frame
with the initiating ATG in the R1 construct dramatically
reduced expression of the SVL9 peptide. Remarkably, the
cells transfected with either the R0 or the R1 constructs were
equivalent in their ability to stimulate the LYL8-speciﬁc T
cells (Figure 2C). To conﬁrm that the CTG initiation codon
was decoded as leucine, we analyzed HPLC fractionated cell
extracts (Figure 2D). Again, a single peak of activity was found
in the fractions that matched the leucine-initiated LYL8
synthetic peptide. Thus, translation of the LYL8 peptide was
independent of upstream conventional translation initiation
events, and translational read-through events were not
detected.
We also considered the possibility that leucine was used as
the ﬁrst amino acid because of an RNA modiﬁcation that
introduced an AUG immediately upstream of the peptide-
coding sequence. However, the experiments below show that
the 59 UTR inﬂuences the leucine start because it is affected
Figure 1. The CUG Initiation Codon Is Decoded as Leucine Independent
of RNA Sequence
(A) The indicated synthetic peptides mixed with extracts from
untransfected COS-7 cells were separated by RP-HPLC. Each fraction
was tested for BCZ103 T cell-stimulating activity with K
bþB7.2
þL cells
as APCs. After overnight incubation, the b-galactosidase induced in
activated T cells was measured using the substrate chlorophenol red-
b-pyranoside, which yields a colored product with absorbance at 595
nm. The arrows indicate the reproducible peak elution times for the
MYL8 and the LYL8 peptides. Injections of buffer alone (Buffer) were
carried out under identical conditions, and the fractions were assayed
in parallel to ensure absence of cross-contamination between runs.
(B–D) Extracts from COS-7 cells transfected with cDNA encoding K
b
and the indicated constructs were separated by RP-HPLC. Fractions
were tested for BCZ103 T cell-stimulating activity as in (A).
(E) The indicated synthetic peptides mixed with extracts from
untransfected COS-7 cells were separated by RP-HPLC. Each fraction
was tested for the speciﬁc DBFZ T cell-stimulating activity with
D
bþB7.2
þ L cells as APCs as in (A). The arrows indicate the
reproducible peak elution times for the MM9 and the LM9 peptides.
(F and G) Extracts from COS-7 cells transfected with cDNA encoding
D
b and the indicated constructs were separated by RP-HPLC.
Fractions were tested for DBFZ T cell-stimulating activity as in (E).
(H) A range of concentrations of the indicated synthetic peptides was
tested for BCZ103 T cell-stimulating activity with K
bþB7.2
þ L cells as
APCs.
(I) A range of concentrations of the indicated synthetic peptides was
tested for DBFZ T cell-stimulating activity with D
bþB7.2
þ L cells as
APCs.
DOI: 10.1371/journal.pbio.0020366.g001
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Cryptic Translation of Antigenic Peptidesby the Kozak context, by the presence of an upstream hairpin,
and by the presence of upstream initiation codons. Together,
these ﬁndings demonstrate that the mRNA remained intact.
The Kozak Context Affects the Efficiency of Initiation at
CUG
The efﬁciency of initiation at a given AUG codon depends
on the identity of the surrounding nucleotides. These
nucleotides, commonly referred to as the ‘‘Kozak context,’’
have a substantial inﬂuence on protein synthesis. Kozak
found that GCCACCAUGG is optimal, and that the nucleo-
tides at positions –3 andþ4 are the most inﬂuential, while the
nucleotide at the –6 position exerts a smaller effect. Changing
these nucleotides can change protein expression by 20-fold
(Kozak 1987a, 1987b). To determine whether the leucine start
was affected by the nucleotides surrounding the CUG
initiation codon, and to allow better prediction of probable
CUG initiation codons, we varied the nucleotides at positions
–6, –3, and þ4 relative to the CUG codon.
We inserted synthetic oligonucleotides *(NCCNCC-
CTGNCC)SEL8* into the pcDNAI vector, where N represents
the degenerate nucleotides ﬂanking the CTG initiation codon
for the SLVELTSL (SEL8) peptide presented by the K
b MHC
molecule to bm1BZ19.4 T cells (Malarkannan et al. 1996). We
transfected COS-7 cells with plasmid DNA from 96 individual
randomly picked bacterial colonies together with the cDNA
for K
b. When the transfected cells were tested for their ability
to stimulate bm1BZ19.4 T cells, we noticed a substantial
variation in the T cell response, suggesting that the plasmids
differed in their ability to express the SEL8 peptide (Figure
3A). As a negative control, none of the cells transfected with
each of the 96 plasmid DNAs encoding the minigene
*(NCCNCCCCCNCC)SEL8* stimulated the T cells, demon-
strating that initiation activity was restricted to the CTG codon
(Figure 3B). To identify which nucleotides were associated with
the variation in peptide expression, we determined the
nucleotide sequences of three sets of 18 CUG-initiated
constructs that yielded high, intermediate, or low T cell
responses (Figure 3C). As summarized in the panels in Figure
3D, among the plasmids that yielded high responses, 70% had
T at position –6, 75% had A at position –3, and 80% had G at
þ4. Conversely, among the plasmids that yielded low responses,
these nucleotides were infrequent. Thus, the optimal context
for the CUG mediated initiation is TCCACCCUGG, which is in
close agreement with Kozak’s consensus sequence (GCCAC-
CAUGG) for the AUG start and extends earlier ﬁndings that
showed that an A atþ5a n dUa tþ6 can also enhance initiation
at the CUG codon (Boeck and Kolakofsky 1994; Grunert and
Jackson 1994). Furthermore, the fact that CUG initiation
activity was inﬂuenced by the Kozak context provides addi-
tional evidence that the CUG codon was decoded during
translation initiation rather than translation elongation.
An Excellent Kozak Context Enhances Both the CUG/
Leucine and the CUG/Methionine Starts
In the above model, because the initiation codon was not
included within the ﬁnal SEL8 antigenic peptide product
protected by the MHC molecule, the identity of the amino
acid residue speciﬁed by the CUG initiation codon could not
be determined. Thus, we could not distinguish whether the
Kozak context affected the leucine start, the methionine start,
or both. To resolve this question, we turned to the (CTG)YL8
model, in which the predominant T cell-stimulating activity is
the leucine-initiated LYL8 peptide (see Figure 1A–1C). At the
–6 and –3 positions, we placed the best (T, A) and the worst
(G, T) nucleotides. We were unable to vary the þ4 position
from the original A, because that would alter the peptide’s
second amino acid and likely affect its detectability by the
BCZ103 T cell hybridoma.
We ﬁrst transfected cells with the two constructs as well as
the appropriate K
b MHC cDNA. After 2 d the transfected
cells were assayed for their ability to stimulate the BCZ103 T
cell. Cells expressing the LYL8 peptide with its CTG initiation
codon in the ‘‘Excellent Kozak’’ context (T at –6, A at –3) were
superior to those with the CTG codon in a ‘‘Poor Kozak’’
context (G at –6, T at –3) in stimulating the T cell response
(Figure 4A). Next, we extracted peptides from the cells
expressing the two constructs and analyzed the antigenic
activities after HPLC fractionation. Again, a single peak of
activity corresponding to the leucine start was detected in the
extract of cells expressing the ‘‘Poor Kozak’’ construct (Figure
4B). In contrast, in the extract from cells expressing the
‘‘Excellent Kozak’’ construct not only was the total amount of
the LYL8 peptide higher, but a new activity peak correspond-
ing to the methionine-initiated MYL8 peptide was also clearly
Figure 2. Expression of the Cryptic LYL8 Peptide Is Independent of the
Efficiency of Upstream Translation Initiation Events
(A) The nucleotide sequences of R0 and R1 constructs encode the
SVL9 peptide followed by a termination codon and the LYL8
peptide. In the R0 construct, the SVL9 peptide is in frame with an
ATG initiation codon. In the R1 construct, a single nucleotide is
inserted after the ATG codon and causes the SVL9*LYL8 coding
sequence to be out-of-frame with the ATG. The in-frame translation
products are underlined and arrows indicate the potential initiation
codons.
(B and C) The R0 and R1 constructs were transfected into Lmtk
– cells
along with the appropriate MHC molecule. They were tested for
SVL9/D
b expression using the 30NX/B10Z hybridoma (B) and LYL8/
K
b expression using the BCZ103 T cell hybridoma (C).
(D) Extracts from COS-7 cells transfected with cDNA encoding K
b
and the indicated constructs were separated by RP-HPLC. Fractions
were tested for BCZ103 T cell stimulating activity as in Figure 1.
DOI: 10.1371/journal.pbio.0020366.g002
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with the response to known quantities of synthetic peptides,
we determined that the construct with the CTG initiation
codon in an ‘‘Excellent Kozak’’ context yielded approximately
6-fold more LYL8 peptide than the construct with CTG in a
poor context. The amount of MYL8 peptide increased as well,
but the change cannot be quantiﬁed, because MYL8 was
undetectable in extracts of cells transfected with the
construct containing the CTG initiation codon in the ‘‘Poor
Kozak’’ context (Figure 4B). We conclude that the Kozak
context enhanced not only the overall efﬁciency of the CTG/
leucine start, but also the ability of the CTG codon to be
decoded in the conventional ‘‘wobble’’ mode as the methio-
nine residue.
Ribosomes Scan 59 to 39 for the CUG Initiation Codon
In most cases, ribosomes bind mRNA at the 59 cap and scan
in the 39 direction for the ﬁrst AUG in an appropriate Kozak
context. Thus, for approximately 90% of mRNA transcripts,
the 59-most AUG initiates protein synthesis (Kozak 1991). In
order to develop predictive algorithms for the CUG initiation
codon, we asked whether ribosomes similarly scanned for the
CUG/leucine start. We took advantage of the fact that a heat-
stable hairpin in the mRNA blocks 40S ribosomal scanning
(Kozak 1986, 1989a). We designed a hairpin based on the one
Kozak used to trap scanning 40S ribosomes (Kozak 1989b). It
extends Kozak’s original sequence in order to maintain
stability at 37 8C, and includes a bulge to prevent the longer
hairpin from targeting the mRNA as a potential substrate for
RNA interference. We placed the hairpin 42 nucleotides
upstream of the initiation codon. To control for nonspeciﬁc
effects, such as RNA stability, we also included GFP under the
control of an IRES element downstream of the peptide-
coding sequence.
We ﬁrst transfected COS-7 cells with constructs encoding
the ATG-initiated MYL8 peptide and another encoding
MYL8 downstream of the heat-stable hairpin. We titrated
the transfected cells and assayed the T cell response to the
peptides presented on the cell surface. As expected, the
presence of the hairpin inhibited MYL8 expression (Figure
5A). This effect was not due to the hairpin destabilizing the
m R N A ,b e c a u s eG F Pe x p r e s s i o na sm e a s u r e db yﬂ o w
cytometry of the same cells was not decreased by the presence
of the hairpin (Figure 5B). Next, we performed the same
experiment with COS-7 cells transfected with the CTG-
initiated peptide with and without an upstream hairpin
sequence and found that the hairpin inhibited translation of
LYL8 as well (Figure 5C). Again, the level of GFP expression
was similar in the cells transfected with constructs with or
without the hairpin (Figure 5D). Similar inhibition of both
ATG- and CTG-initiated translation was also observed with a
second set of constructs in which the hairpin was placed 68
nucleotides upstream of the initiation codon, making it less
likely that the hairpin interfered with a potential IRES-like
ribosomal landing pad (unpublished data). Both conven-
tional, ATG-mediated and cryptic, CTG-mediated translation
events were disrupted by upstream hairpins, suggesting that
both require ribosomal scanning in the 59-to-39 direction.
A Set of Ribosomes Is Scanning Specifically for the CUG/
Leucine Start
We next asked whether ribosomes responsible for the CUG/
leucine start were scanning speciﬁcally for CUG initiation
codons, or whether they were able to start at conventional
AUG initiation codons as well. To address this question, we
placed ‘‘decoy’’ ATG and CTG codons upstream of and out of
frame with the CTG codon initiating expression of the
peptide, and asked whether their presence affected peptide
translation.
As a positive control, we transfected cells with a construct
encoding the ATG-initiated MYL8 and another encoding the
same MYL8 peptide but with three ATGs upstream of and out
Figure 3. The Optimal Nucleotide Context for the CUG Initiation Codon
(A and B) The indicated degenerate oligonucleotides were cloned
into the pcDNA1 vector. ‘‘N’’ represents any one of T, A, C, and G
nucleotides. The CTG or CCC initiation codons are boxed and the
peptide coding sequence is indicated by [SEL8]. 96 randomly picked
plasmids for the CTG-initiated peptide and an equal number for the
CCC-initiated peptide were puriﬁed. The plasmids were transfected
into COS-7 cells along with the K
b MHC class I molecule, and the T
cell response was measured. Each bar represents the T cell response
to cells transfected with an individual plasmid.
(C) Three sets of 18 representative plasmids, each yielding high,
intermediate, and low responses (as shown) were selected for
nucleotide sequencing.
(D) Summary of the nucleotide sequences of plasmids yielding high,
intermediate, and low responses. The left, middle, and right panels,
respectively, correspond to the plasmids shown in (C). Each panel
shows the percent of each nucleotide found at the –6, –3, and þ4
degenerate positions indicated by the ‘‘N’’ in A. For example, the
upper left square shows that, of the high T cell-stimulating plasmids,
the –6 position was T for 67%, A for 6.7%, C for 20%, G for 6.7%, a
pyrimidine (T or C) for 87%, and a purine (A or G) for 13%.
DOI: 10.1371/journal.pbio.0020366.g003
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had CAGs instead of ATGs, because the CAG codon does not
possess initiation activity. As expected, the presence of
upstream out-of-frame ATGs dramatically reduced ATG-
initiated MYL8 peptide expression. The reduction in MYL8
peptide was seen both when the transfected cells were used
directly to stimulate T cells and when peptides from the
transfected cells were extracted, separated by HPLC, and
then assayed with T cells (Figure 6A and 6B). This result is in
complete agreement with the scanning model of translation
initiation. The marked reduction in peptide expression
occurs because ribosomes initiate translation at the ﬁrst
AUG and traverse the downstream peptide-coding region in
the wrong reading frame; the ribosomes that missed the ﬁrst
AUG would start at the second or the third AUG and also
traverse the peptide coding region in the wrong reading
frames (Bullock and Eisenlohr 1996; Bullock et al. 1997).
We then transfected cells with a construct encoding
(CTG)YL8 and another encoding (CTG)YL8 with three ATGs
upstream of and out of frame with the peptide (ATG)3CTG.
When the transfected cells were used directly to stimulate T
cells, the upstream ATGs had little effect (Figure 6C).
Figure 4. The Kozak Context Enhances the
Leucine as well as the ‘‘Wobble’’ Methio-
nine Start
(A) Lmtk
– cells were transfected with K
b
cDNA and the indicated ‘‘Excellent’’ and
‘‘Poor’’ constructs encoding the
(CTG)YL8 peptide. They were tested for
LYL8/K
b expression using the BCZ103 T
cell hybridoma.
(B) Extracts from COS-7 cells transfected
with cDNA encoding K
b and the indi-
cated constructs were separated by RP-
HPLC. Fractions were tested for BCZ103
T cell-stimulating activity with K
bþB7.2
þ
L cells as APCs. The arrows indicate the
peak elution positions for the MYL8 and
the LYL8 peptides. T cell responses to
fractions collected after injecting sample
buffer alone (Buffer) are also shown to
indicate absence of cross-contamination
between runs.
DOI: 10.1371/journal.pbio.0020366.g004
Figure 5. The CUG Start Is Blocked by a
Heat-Stable Hairpin in the 59 UTR
COS-7 cells were transfected with cDNA
encoding K
b and the indicated con-
structs. (A and C) The cells were titrated
and peptide expression was tested with
BCZ103 T cells. (B and D) GFP expres-
sion in the transfected cells was assayed
by ﬂuorescence-activated cell sorting.
GFP ﬂuorescence (shaded histograms) is
not observed in untransfected cells (or in
cells transfected with a vector not
encoding GFP [unpublished data]).
DOI: 10.1371/journal.pbio.0020366.g005
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fected cells revealed that the upstream ATGs virtually
abolished expression of the MYL8 peptide, whereas LYL8
expression was not affected (Figure 6D). Thus, upstream out-
of-frame ATG initiation codons inhibited the conventional
‘‘wobble’’ CUG/methionine start, but not the CUG/leucine
start.
Finally, we transfected COS-7 cells with constructs encod-
ing (CTG)YL8 with three CTGs upstream of and out of frame
with the peptide (CTG)3CTG. When the transfected cells were
used directly to stimulate T cells, we saw a small but
consistent inhibition (Figure 6E). Remarkably, HPLC analysis
of the transfected cell extracts showed that only LYL8
expression was decreased without any change in the
expression of the MYL8 peptide (Figure 6F). The observation
that upstream ATGs inhibit the wobble start but not the
leucine start, and that upstream CTGs inhibit the leucine
start but not the wobble start, suggests that a separate set of
ribosomes is scanning for the CUG/leucine start, distinct from
the ribosomes used for the methionine start.
Note, however, that the upstream CUGs, despite an
‘‘Excellent Kozak’’ context, inhibited the leucine start weakly.
This effect contrasts with the inhibition caused by the
upstream AUGs on the AUG/methionine or the CUG/
methionine starts and suggests that other features are
required for an efﬁcient CUG/leucine start. Interestingly,
one form of the ASCT2 amino acid transporter is initiated
with multiple CUG and GUG codons in close proximity
(Tailor et al. 2001). This redundancy may be required if any
given non-AUG codon is used inefﬁciently. Furthermore,
many mRNAs with CUG starts have GC-rich regions
immediately downstream from the initiation codon and have
been hypothesized to form hairpins that cause the ribosome
to pause long enough to recognize the CUG codon (Kozak
1990).
The Leucine Start Is Enhanced in the Presence of
Phosphorylated Eukaryotic Translation Initiation Factor 2a
Finally, we were interested to know whether the leucine
start requires eukaryotic translation initiation factor 2 (eIF2),
Figure 6. Ribosomes Are Scanning Specif-
ically for the CUG/Leucine Start
(A, C, and E) Lmtk
– cells were transfected
with the indicated constructs and K
b
cDNA. After 2 d they were tested for
MYL8/K
b or LYL8/K
b expression using
the BCZ103 T cell hybridoma. Error bars
represent the standard deviation of
three replicate wells. (ATG)3ATG (solid
circles, A) denotes the ATG-initiated
peptide preceded by three ATGs up-
stream of and out of frame with the
peptide; (CAG)3ATG (open circles, A) is
the identical DNA construct but the
upstream ATGs were replaced with
CAG. (ATG)3CTG (solid circles, C) de-
notes the CTG-initiated peptide pre-
ceded by three ATGs upstream of and
out of frame with the peptide;
(CAG)3CTG (open circles, C) is the
identical DNA construct but the up-
stream ATGs were replaced with CAG.
(CTG)3CTG (solid circles, E) denotes the
CTG-initiated peptide preceded by three
CTGs upstream of and out of frame with
the peptide; (CAG)3CTG (open circles, E)
is the identical DNA construct but the
upstream CTGs were replaced with CAG.
(B, D, and F) Extracts from COS-7 cells
transfected with cDNA encoding K
b and
the indicated constructs were separated
by RP-HPLC. Fractions were tested for
BCZ103 T cell-stimulating activity with
K
bþB7.2
þ L cells as APCs. Arrows indi-
cate the peak elution positions of the
MYL8 and the LYL8 peptides. Points on
graphs correspond to those in (A), (C),
and (E).
DOI: 10.1371/journal.pbio.0020366.g006
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Cryptic Translation of Antigenic Peptideswhich is responsible for loading the RNAi
Met onto the 40S
ribosome. Cells target eIF2 by phosphorylating its a subunit
(eIF2a) to inhibit protein synthesis in response to a number
of stress signals, including viral infection, starvation, and the
accumulation of unfolded proteins. Ribosomes release eIF2-
guanosine diphosphate (GDP) after the AUG initiation codon
is reached, and GDP is exchanged for guanosine triphosphate
(GTP) with the assistance of another protein, eIF2B, before
eIF2 can be used for another round of translation initiation.
When eIF2a is phosphorylated, it binds eIF2B with unusually
high afﬁnity and thus prevents subsequent nucleotide
exchange. Because eIF2B is limiting in the cell, phosphor-
ylation of only a fraction of eIF2a can substantially inhibit
translation globally (Hershey and Merrick 2000).
To approach this question, we transfected HeLa cells with
(CTG)YL8 or (ATG)YL8 constructs. We then assayed peptide
expression in cells that had or had not been treated to induce
phosphorylation of eIF2a. It was a challenge to induce
phosphorylation of eIF2a for long enough to see an effect
on peptide expression without causing substantial toxicity.
Furthermore, we could not disrupt peptide/MHC assembly in
the endoplasmic reticulum, a requirement that ruled out
standard reagents such as dithiothreitol, thapsigargin, and
tunicamycin. We also did not want to inhibit peptide
elongation, which ruled out amino acid starvation.
The optimal treatment for our purposes was sodium
arsenite (NaAs). Arsenite reacts with sulfhydryl groups and
causes phosphorylation of eIF2a presumably by inducing an
unfolded protein response, although the precise mechanism
remains unknown (Brostrom and Brostrom 1998). We trans-
fected HeLa cells with DNA encoding the CTG and ATG-
initiated peptides. After 12 h, we treated the cells with 50 lM
NaAs for 4 h before assaying them for expression of eIF2a
and peptides. Western blot analysis conﬁrmed that the
amount of phosphorylated eIF2a in NaAs-treated cells was
enhanced (Figure 7A). As a control, the amount of tubulin in
the cells remained unchanged.
We assayed the HeLa cells for peptide expression using the
BCZ103 T cell hybridoma (Figure 7B). We found that
expression of the ATG-initiated MYL8 peptide was reduced
by NaAs, as expected. The reduction was dramatic because
the effect of NaAs was equivalent to the effect of brefeldin A,
which stops protein transport from the endoplasmic retic-
ulum to the Golgi and thus prevents any new peptides from
trafﬁcking to the cell surface. Surprisingly, expression of the
CTG-initiated LYL8 peptide increased upon NaAs treatment,
although it too was inhibited by brefeldin A treatment. This
result was consistent in six independent experiments. The
difference in ATG versus CTG initiation is not likely due to a
unique effect of NaAs that somehow stabilizes LYL8 and not
MYL8, because an alternative method of inducing phosphor-
ylation of eIF2a using b-interferon and polyIC (Savinova and
Jagus 1997; Kaufman 2000), gave similar reproducible results
(unpublished data). We conclude that, in contrast to
initiation at conventional AUG codons, initiation at the
CUG/leucine codon was eIF2a-independent.
The effect of eIF2a phosphorylation on the leucine start
strikingly mirrors the effect of eIF2a phosphorylation on
proteins whose synthesis is directed by the CPV-IRES, which
does not require eIF2 (Wilson et al. 2000). Intriguingly, eIF2-
independence of the CUG start is consistent with the
observation of Donahue et al. (1988) that mutations in a
Zn(II) ﬁnger domain of eIF2b permit initiation at a UUG
codon. The data implicates the nucleic acid-binding
function of eIF2b in start-site selection (Donahue et al.
1988; Huang et al. 1997). Identiﬁcation of the factors
required for the CUG start will illuminate not only leucine
Figure 7. The Leucine Start Is Enhanced in the Presence of
Phosphorylated eIF2a
HeLa cells transfected with cDNA encoding K
b together with cDNA
encoding either the ATG- or CTG- initiated peptides were treated for
4 h with 50 lM NaAs, with brefeldin A (BfA), or left untreated (UT).
(A) Transfected cells treated with NaAs or without (UT) were lysed
and tested for phosphorylation of eIF2a by Western blot and for
tubulin as a loading control.
(B) The transfected cells were titrated and tested for their ability to
stimulate BCZ103 T cells.
DOI: 10.1371/journal.pbio.0020366.g007
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Cryptic Translation of Antigenic Peptidesinitiation, but also the role of these components in the
methionine start.
The CPV-IRESs are to date the only known sequences that
allow eIF2-independent initiation in eukaryotic cells. Viruses
employ a host of creative strategies to prevent phosphor-
ylation of eIF2a (Kaufman 2000). Initiation at non-AUG
codons, which is relatively common in viral transcripts, may
provide a way to continue translation despite the lack of
eIF2. Similarly, despite general translational inhibition
during viral infection, cells need to continue generating
antigenic peptides to ﬂag down T cells. In addition to viral
proteins and antigenic peptides, a number of regulatory
cellular proteins have non-AUG initiation codons. For
example, c-Myc has two distinct isoforms, the longer of
which is initiated with CUG and may inhibit proliferation, as
it is absent in a number of tumor-derived cell lines.
Intriguingly, synthesis of the CUG-initiated form increases
when cells reach high density, speciﬁcally when methionine is
limiting (Hann et al. 1988; Hann et al. 1992). It should be
interesting to test whether this and other CUG-initiated
proteins have a leucine start. In addition, whether other non-
AUG initiation codons such as GUG or ACG are decoded in a
manner similar to the CUG codon described here remains to
be determined.
In summary, we found that when CUG acts as an alternate
initiation codon, it can be decoded as leucine as well as
methionine. The leucine start does not depend on mRNA
structure or sequence, but its efﬁciency can be enhanced by
the Kozak context. A set of ribosomes is scanning 59 to 39
speciﬁcally for the CUG initiation codon. While the methio-
nine start is inhibited when cells are treated with NaAs, the
leucine start is enhanced, suggesting that leucine initiation is
independent of eIF2. This novel translation initiation
mechanism provides cells not only antigenic peptides but
also a potential tool for translational control.
Materials and Methods
Cell lines. Lmtk
–, COS-7, K
bþB7.2
þ L, D
bþB7.2
þ L, BCZ103, 30NX/
B10Z, and DBFZ cells have been described (Mendoza et al. 1997;
Malarkannan et al. 1999). Cell lines were maintained at 37 8C with 5%
CO2 in RPMI 1640 with 10% fetal bovine serum, 1 mM sodium
pyruvate, 50 lM b-mercaptoethanol, 0.3 mg/ml glutamine, 100 U/ml
penicillin, and 100 lg/ml streptomycin (normal medium). HeLa cells
were obtained from ATCC (#CCL-2; Manassas, Virginia, United
States), and cultured in Eagle’s minimal essential medium modiﬁed
with Earle’s balanced salt solution, nonessential amino acids, 2 mM L-
glutamine, 1 mM sodium pyruvate, 1500 mg/l sodium bicarbonate
(ATCC #30–2003), 10% fetal bovine serum, and 10 lg/ml ciproﬂox-
acin.
Plasmid construct sequences. Sequences for constructs depicted in
Figure 1 are as follows. CTG-YL8 in the BstXI/XbaI sites of the
pcDNA1 vector (Invitrogen, Carlsbad, California, United States), 59-
TGTGTAGCTGACCTTCAACTACCGGAATCTATAGCTAG-39;
CTG-YL8 in the EcoRI/BamHI sites of the pIRES2-eGFP vector
(Clontech, Palo Alto, California, United States), 59-AATTAGAC-
GAAGGTCTAGCTGACCTTCAACTACCGTAACCTGTAGATC-39;
CTG-YL8 in the HindIII/BamHI sites of the pcDNA1 vector with GFP
in the EcoRI site, 59-AGCTAGCTGACCTTCAACTACCGGAATCTA-
TAGATCGATC-39; ATG-YL8 in the EcoRI/BamHI sites of the
pIRES2-eGFP vector, 59-AATTAGACGAAGGTCTAGATGACCTT-
CAACTACCGTAACCTGTAGATC-39; CTG-M9 in the BstXI/XbaI
sites of the pcDNA1 vector, 59-TGTGTAGCTGAGCAACGAGAA-
CATGGAGACCATGTAGTGCACTAG-39; and ATG-M9 in the BstXI/
XbaI sites of the pcDNA1 vector, 59-TGTGTAGATGAGCAACGA-
GAACATGGAGACCATGTAGTGCACTAG-39.
Sequences for constructs depicted in Figure 2 are as follows. R0
in the BstXI/XbaI sites of the pcDNA1 vector, 59-TGTGTAGAT-
GAGCAGCGTCGTCGGCGTTTGGTACCTCTAGCTGACCTTCAAC-
TACCGGAATCTCTAG-39; and R1 in the BstXI/XbaI sites of the
pcDNA1 vector, 59-TGTGTAGATGGAGCAGCGTCGTCGG-
CGTTTGGNACCTCTAGCTGACCTTCAACTACCGGAATCTCTAG-39.
Sequences for constructs depicted in Figure 3 are as follows. CTG-
initiated peptide in the BstXI/XbaI sites of the pcDNA1 vector, 59-
TGTGTAGNCCNCCCTGNCCAGTGTTGTTGAATTCTCCAGCCTC-
TAG-39; and CCC-initiated peptide in the BstXI/XbaI sites of the
pcDNA1 vector, 59-TGTGTAGNCCNCCCCCNCCAGTGTTGTT-
GAATTCTCCAGCCTCTAG-39.
Sequences for constructs depicted in Figure 4 are as follows.
‘‘Excellent Kozak’’ CTG-YL8 in the BstXI/XbaI sites of the pcDNA1
vector, 59-TGTGTAGTCGACCCTGACCTTCAACTACCGGAATCTC-
TAG-39; and ‘‘Poor Kozak’’ CTG-YL8 in the BstXI/XbaI sites of the
pcDNA1 vector, 59-TGTGTAGGCGTCCCTGACCTTCAACTACCG-
GAATCTCTAG-39.
Sequences for constructs depicted in Figure 5 are as follows. CTG-
YL8 or ATG-YL8 in the pIRES2-eGFP vector, as in Figure 1 hairpin
CTG-YL8 or ATG-YL8 in the pIRES2-eGFP vector (sequence from 59
cap to start of peptide, whose sequence is as in Figure 1): 59-
GCTAGCGCTACCGGACTCAGATCGTGTCCGGATTTGGGG-
CGCGTGGTGGCGGCTTTTCGCGCGCGCGACGCGTCGCGCGCG-
CGTTTTGCCGCCACCACGCGCCCCTTTAGTACTTGAGCT-
CAAGCTTCGAATTAGACGAAGGTCTAG-39.
Sequences for constructs depicted in Figure 6A and 6B are as
follows. CAG3ATG-YL8 in the BstXI/XbaI sites of the pcDNA1 vector,
59-TGTGAACCCAGGGTCGACCCAGGACCCAGGTAGTCGACCAT-
GACCTTCAACTACCGGAATCTCTAG-39; and ATG3ATG-YL8 in the
BstXI/XbaI sites of the pcDNA1 vector, 59-TGTGAACCATGGGTC-
GACCATGGACCATGGTAGTCGACCATGACCTTCAACTACCG-
GAATCTCTAG-39.
Sequences for constructs depicted in Figure 6C and 6D are as
follows. CAG3CTG-YL8 in the BstXI/XbaI sites of the pcDNA1 vector,
59-TGTGAACCCAGGGTCGACCCAGGACCCAGGTAGTCGACCCT-
GACCTTCAACTACCGGAATCTCTAG-39; and ATG3CTG-YL8 in the
BstXI/XbaI sites of the pcDNA1 vector, 59-TGTGAACCATGGGTC-
GACCATGCACCATGGTAGTCGACCCTGACCTTCAACTACCG-
GAATCTCTAG-39.
Sequences for constructs depicted in Figure 6E are as follows.
CAG3CTG-YL8 in the HindIII/XbaI sites of the pcDNA1 vector
mutated to alter the two CTGs in the 59 UTR to CAG, 59-
AGCTACAAACAGGATTACAAACAGGATTACAAACAGGATTA-
CAAACAGGATTACAAACAGGATTACAAACAGGATTACAAACAG-
GATTACAAACAGGATTACAAACAGGATTTAGAAACTGACCTT-
CAACTACCGGAATCTCTAG-39; and CTG3CTG-YL8 in the HindIII/
XbaI sites of the pcDNA1 vector mutated to alter the two CTGs in the
59 UTR to CAG, 59-AGCTACAAACAGGATTACAAACAGGATTA-
CAAACAGGATTACAAACAGGATTACAAACAGGATTACAAACAG-
GATTACAAACTGGATTACAAACTGGATTACAAACTGGATTTA-
GAAACTGACCTTCAACTACCGGAATCTCTAG-39
Sequences for constructs depicted in Figure 6F are as follows.
CAG3CTG-YL8 in the HindIII/XbaI sites of the pcDNA1 vector, 59-
AGCTACAAACAGGNTTACAAACAGGATTACAAACAGGATTA-
CAAACAGGATTACAAACAGGATTACAAACAGGATTACAAACAG-
GATTACAAACAGGATTACAAACAGGATTTAGAAACTGACCTT-
CAACTACCGGAATCTCTAG-39; and CTG3CTG-YL8 in the HindIII/
XbaI sites of the pcDNA1 vector, 59-AGCTACAAACAGGATTA-
CAAACAGGATTACAAACAGGATTACAAACAGGATTACAAACAG-
GATTACAAACAGGATTACAAACTGGATTACAAACTGGATTA-
CAAACTGGATTTAGAAACTGACCTTCAACTACCGGAATCTC-
TAG-39.
Sequences for constructs depicted in Figure 7 are as follows. CTG-
YL8 in the in the BstXI/XbaI sites of the pcDNA1 vector, 59-
TGTGTAGCTGACCTTCAACTACCGGAATCTGTAGCTAG-39;
ATG-YL8 in the in the BstXI/XbaI sites of the pcDNA1 vector, 59-
TGTGAAAAACAGGCCAAACAGGCCAAACAGGAAGATGACCTT-
CAACTACCGGAATCTCTAG-39.
Transfections. The DEAE-dextran transfection method was used in
Figures 2B and 2C, 3, 4A, 6A, 6C, and 6E. It has been described
previously (Serwold et al. 2001). Brieﬂy, Lmtk
– or COS-7 cells were
transfected in 96-well plates (1310
4 cells per well) with the indicated
concentration of plasmid DNA, 0.1 mg/ml DEAE-dextran, 0.1 mM
chloroquine, 10 ng/ml MHC class I cDNA, 5 ng/ml B7.2 cDNA, and
10% NuSerum (Collaborative Biomedical Products, Becton Dick-
inson, Bedford, Massachusetts, United States) in RPMI 1640. After 90
min, the cells were shocked with 10% DMSO in PBS for 2 min. After 2
d incubation in normal medium, T cells (1 3 10
5 cells per well) were
added to assay peptide expression. GeneJuice (Novagen, Madison,
Wisconsin, United States) transfection reagent was used in Figures 1,
2 D ,4 B ,5 ,6 B ,6 D ,6 F ,a n d7 .I tw a su s e da c c o r d i n gt ot h e
manufacturer’s instructions, except that we used 8 ml of medium, 8
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DNA per 10-cm dish. Peptide expression in the transfected cells was
assayed after 2 d by titrating intact cells or after fractionating the cell
extracts by HPLC.
T cell assay. The T cell assay has been described previously
(Sanderson and Shastri 1994). Brieﬂy, Lac Z-inducible T hybridomas
(1310
5 cells) were incubated with APCs in 96-well plates for 6–24 h.
The response, accumulation of intracellular b-galactosidase, was
measured with the substrate chlorophenol red-b-D-galactopyranoside
(CPRG). The product was measured with a 96-well plate reader at 595
nm and 655 nm as the reference wavelength.
HPLC. The HPLC assay has been described previously (Serwold et
al. 2001). Brieﬂy, 2 d after transfection, cells were lysed in 10% formic
acid, and the lysate was passed through a 10 kDa cutoff ﬁlter
(Millipore, Bedford, Massachusetts, United States). The ,10 kDa
fraction was injected onto a 2.1 3 250 mm C18 column (Vydac,
Hesperia, California, United States) and separated by RP-HPLC, with
0.1% TFA in water as the polar buffer and 0.1% TFA in acetonitrile
as the nonpolar buffer. Three-drop fractions (except analysis of xM9,
with ﬁve-drop fractions) were collected in 96-well plates, dried in a
vacuum centrifuge, and analyzed by the addition of APCs (5310
4 per
well) and T cell hybridomas (1 3 10
5 cells per well).
eIF2a phosphorylation. Cells were transfected with GeneJuice
(Novagen) as described above, but the transfection medium was left
on for only 4 h before the cells were lifted and split into multiple
dishes with fresh medium. Cells were allowed to rest for 12 h before
sodium arsenite treatment. They were treated with 50 lM NaAs
(Sigma, St. Louis, Missouri, United States), 13 GolgiPlug containing
brefeldin A (PharMingen, San Diego, California, United States), or
left untreated for 4 h. The cells were then lifted and counted. For the
T cell assay, they were titrated in a 96-well plate. The assay was as
described above, except that 13 GolgiPlug was added in order to
‘‘freeze’’ the cells in their state at the end of treatment. For the
Western blot, they were incubated on ice for 5–10 min in lysis buffer
(20 mM HEPES [pH 7.5], 150 mM NaCl, 1% Triton X-100, 10%
glycerol, 1 mM EDTA, 10 mM tetrasodium pyrophosphate, 100 mM
NaF, 17.5 mM b-glycerophosphate, 0.4 U/ml aprotinin, 10 lg/ml
leupeptin, 1 mM PMSF, 0.1 mM pepstatin A, and complete protease
inhibitor cocktail [Roche, Basel, Switzerland]). The lysate was spun for
15 min at 4 8C, and the supernatant was transferred to a tube
containing an equal volume of 23SDS-PAGE sample buffer (100 mM
Tris-HCl [pH 6.8], 20% glycerol, 4% SDS, bromophenol blue, and 5%
b-mercaptoethanol). The sample was then heated in water just off the
boil for 5 min, separated on a 10% SDS-PAGE gel, and transferred to
a nitrocellulose membrane. The membrane was blocked for 1 h at
room temperature in TBS–0.1% Tween 20–5% bovine serum
albumin (TBS, 0.02 M Tris-HCl [pH 7.6] with 0.137 M NaCl),
incubated for 1 h with primary antibody (#44–728, at a 1:2000
dilution; Biosource, Camarillo, California, United States) in TBS–
0.1% Tween 20–5% bovine serum albumin, washed four times for 5
min with TBS–0.1% Tween 20, incubated for 40 min with secondary
antibody (anti-rabbit-HRP #NA934V, at a 1:30,000 dilution; Amer-
sham, Little Chalfont, United Kingdom), washed four times for 5 min
with TBS–0.1% Tween 20, incubated for 5 min in substrate
(SuperSignal West Femto Maximum Sensitivity Substrate, #34095;
Pierce Biotechnology, Rockford, Illinois, United States), and exposed
to ﬁlm. An antibody to a-tubulin (#sc-5546; Santa Cruz Biotechnol-
ogy, Santa Cruz, California, United States) was used as a loading
control.
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